Multiple Sclerosis- Upcoming Novel Therapies Will Act as Market Drivers
Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord in which the immune system attacks the myelin sheath. The disease can cause the nerves to weaken or become permanently damaged. Although the exact cause is unknown, the disease is considered to be an autoimmune disease. There are mainly four types of MS namely Relapsing-remitting multiple sclerosis (RRMS), Secondary-progressive multiple sclerosis (SPMS), Primary-progressive multiple sclerosis (PPMS), Benign multiple sclerosis. MS typically begins between the ages of...
View full press release